Caris Life Sciences Stock
carislifesciences.com | BioTech | Funding to Date: $465,000,000
Operator of a biotechnology company specializing in cancer treatment agents. The company is a provider of molecular science focused on fulfilling the promise of precision medicine and facilitating a deeper understanding of cancer biology and other complex diseases through a suite of molecular profiling offerings assess DNA, RNA and proteins that reveal the molecular blueprint, enabling physicians and cancer patients to make more precise and personalized treatment decisions.
Get data-based research, detailed reports, and unique insights on
private companies and trends.